| |
|
|
|
Cleveland BioLabs Inc.  
|
|
1.98 0.08 (0.04%) |
09-21 16:00 |
|
Open: |
1.91 |
Pre close: |
1.9 |
Target:
|
2.49 
|
|
High: |
1.98 |
Low: |
1.9158 |
Resistance:
|
2.13
2.49
|
|
Volume: |
4,101 |
Market Cap: |
22M |
Support:
|
1.90
1.76
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.92
|
MACD |
MACD(12,26):
|
-0.05 |
|
MA(20): |
1.89  |
Signal(12,26,9): |
-0.08 |
|
MA(100): |
2.39 |
Stochastic Oscillator |
%K(14,3):
|
62.67 |
|
MA(250): |
2.89 |
%D(3): |
56.44 |
|
Average Volume(K) |
3-Month: |
1840
|
52-Week |
High:
|
4.25 |
|
10-Days: |
546 |
Low: |
1.76 |
|
RSI |
RSI(14):
|
51.29 |
Change(%): |
-42.8 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-186.1 |
Shares Out. (M) |
11.30 |
|
EPS Est. Current Year |
-0.160 |
Return on Assets (ttm) |
-46.1 |
Shares Float (M) |
7.64 |
|
EPS Est. Next Year |
-0.480 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
89.9 |
% Held by Institutions |
4.60 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
22 |
|
Book Value (p.s.) |
155.660 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.01 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-4.99 |
P/S |
139837504.00 |
|
Operating Margin |
-297.53 |
Levered Free Cash Flow
(M) |
-3.64 |
P/CF |
-4.48 |
|
|
|
|
|
|
